Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma

Abstract

This paper reports on both Isa interference with M-protein measurement and depth of response kinetics with Isa-Pd from the ICARIA-MM study.

Keywords

• minimal residual disease
• survival
• criteria
• outcomes
• therapy